AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇰🇪
Rivaroxaban in Kenya
28 products registered with PPB — 28 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| RIVABA 10 Tablet | H2025/CTD12685/25430 | ZAIN PHARMA LIMITED | active | 15 Sept 2030 |
| RIVABA 15 Tablet | H2025/CTD12687/25431 | ZAIN PHARMA LIMITED | active | 15 Sept 2030 |
| RIVABA 20 Tablet | H2025/CTD12686/25432 | ZAIN PHARMA LIMITED | active | 15 Sept 2030 |
| RIVAFLO 15 Tablet | H2025/CTD12159/21080 | MSN Laboratories Private Limited. | active | 27 Aug 2030 |
| Roxiclot 2.5mg tablets Film-Coated Tablet | H2025/CTD11332/24774 | Dawa Limited | active | 26 May 2030 |
| Rivaxored 10 mg Tablet | H2025/CTD12524/27049 | DR. REDDY’S LABORATORIES LIMITED | active | 24 Apr 2030 |
| Rivaxored 20 mg Tablet | H2025/CTD12566/27051 | DR. REDDY’S LABORATORIES LIMITED | active | 24 Apr 2030 |
| Rivaxored 15 mg Tablet | H2025/CTD12525/27050 | DR. REDDY’S LAdORATORIES LIMITED | active | 24 Apr 2030 |
| Rivaxo Tablets 20mg Film-Coated Tablet | H2024/CTD11125/24011 | GETZ PHARMA (PRIVATE) LIMITED | active | 16 Sept 2029 |
| Rivaxo Tablets 10mg Film-Coated Tablet | H2024/CTD11123/24008 | GETZ PHARMA (PRIVATE) LIMITED | active | 31 Jul 2029 |
| Rivaxo Tablets 15mg Film-Coated Tablet | H2024/CTD11124/23998 | GETZ PHARMA (PRIVATE) LIMITED | active | 22 May 2029 |
| RIVAFLO 20 Tablet | H2024/CTD10438/21081 | MSN LABORATORIES PRIVATE LIMITED.. | active | 25 Mar 2029 |
| iXarola 10mg Film-coated tablet Film-Coated Tablet | H2022/CTD10415/22720 | Bayer AG | active | 25 Jul 2028 |
| iXarola 15mg Film-coated tablet Film-Coated Tablet | H2022/CTD10400/22721 | Bayer AG | active | 24 Jul 2028 |
| iXarola 20mg Film-coated tablet Film-Coated Tablet | H2022/CTD10395/22722 | Bayer AG | active | 24 Jul 2028 |
| Xalia Tablet 15mg Film-Coated Tablet | H2022/CTD9661/21009 | CCL Pharmaceuticals (Pvt.) Ltd. | active | 9 Nov 2027 |
| Xalia Tablet 20mg Tablet | H2022/CTD9566/21006 | CCL Pharmaceuticals (Pvt.) Ltd. | active | 9 Nov 2027 |
| RIVAGLAX-10 Film-Coated Tablet | H2022/CTD9175/20920 | GALAXY PHARMACEUTICAL LIMITED | active | 21 Sept 2027 |
| RIVAGLAX-20 Tablet | H2022/CTD9177/20940 | GALAXY PHARMACEUTICAL LIMITED | active | 21 Sept 2027 |
| RIVAGLAX-15 Tablet | H2022/CTD9176/20933 | GALAXY PHARMACEUTICAL LIMITED | active | 21 Sept 2027 |
| Varoxa-10 Film-Coated Tablet | H2022/CTD8201/16872 | Micro Labs Limited | active | 12 Sept 2027 |
| Varoxa-20 Film-Coated Tablet | H2022/CTD8684/16870 | Micro Labs Limited | active | 12 Sept 2027 |
| Riva-Q 10mg Tablet Tablet | H2022/CTD9044/20696 | Q PHARMA DMCC | active | 2 Jun 2027 |
| Xaroban Tablets 10mg Tablet | H2022/CTD8946/16445 | THE SEARLE COMPANY LIMITED | active | 10 Apr 2027 |
| Riva-Q 20mg tablet Tablet | H2021/CTD8438/18582 | Q PHARMA DMCC | active | 1 Sept 2026 |
| Riva-Q 15mg tablet Tablet | H2021/CTD8453/18575 | Q PHARMA DMCC | active | 1 Sept 2026 |
| RIVATAS 10 Tablet | H2021/CTD8294/17280 | INTAS PHARMACEUTICALS LIMITED | active | 1 Sept 2026 |
| RIVATAS 20 Tablet | H2021/CTD8276/17281 | INTAS PHARMACEUTICALS LIMITED | active | 27 Aug 2026 |
Rivaroxaban — PPB Registration Details
PPB (Kenya) has 28 registered products containing Rivaroxaban, of which 28 are currently active. Data is sourced directly from the official PPB drug register and refreshed daily.
Track Rivaroxaban registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.